Abbott Laboratories (Abbott), via its wholly owned subsidiary Badger Merger Sub I, Inc, proposes to acquired 100% of the shares in Exact Sciences Corporation (Exact Sciences) through an Agreement and Plan of Merger.
Abbott is a global healthcare company, headquartered in the US, active in the provision of diagnostics, medical devices, nutrition, and branded generic pharmaceuticals.
Exact Sciences is a US headquartered company active in the provision of advanced molecular diagnostics, specialising in cancer screening, precision oncology diagnostics, and genetic testing.
The parties both supply oncological diagnostic products in Australia.
2 Feb 2026
24 Feb 2026
Approved
Abbott Laboratories - Exact Sciences - Phase 1 determination
Exact - Phase 1 determination without conditions - 24 Feb 2026.pdf(158.07 KB)